In Memoriam: Michael R. Green, MD, PhD
Research Focus - Discovery of Therapeutically Targetable Pathways in Cancer
- Identification of new genes and regulatory pathways that promote or prevent cancer using transcription-based approaches, functional screens (RNAi and CRISPR) and genomics methods
- Elucidation of cancer drug resistance mechanisms
- Modulation of gene expression as a therapeutic approach
- Development of new gene therapy approaches, such as AAV-mediated delivery of secreted tumor suppressor proteins (with Guangping Gao)
Representative Publication
Ma L, Pak ML, Ou J, et al. Prosurvival kinase PIM2 is a therapeutic target for eradication of chronic myeloid leukemia stem cells. Proc Natl Acad Sci USA. 2019;116(21):10482-10487.
In the News
Getting Results…
-
Read more
-
UMass Cancer Center funds five UMass Chan research projects
Read more -
Michael Green named vice provost for strategic research initiatives
Read more -
Michael Green and Allan Jacobson elected to American Academy of Arts and Sciences
Read more -
Synergy among 40 scientists at Li Weibo Institute for Rare Diseases Research accelerates discovery
Read more -
Michael Green appointed director of UMass Cancer Center
Read more